Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Cole

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Infection|November 5, 2023
Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022Victoria J Hall, Ferdinando Insalata, Sarah Foulkes, et al.
Infection and Immunity|March 28, 2018
Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial InfectionDouglas J Fraser-Pitt, Derry K Mercer, Daniel Smith, et al.
Health Technology Assessment (Winchester, England)|May 18, 2019
Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCTJonathan Dc Ross, Jan Harding, Lelia Duley, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2016
Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapyMarcus J Pond, Catherine L Hall, Victoria F Miari, et al.
Lancet (London, England)|May 7, 2019
Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trialJonathan D C Ross, Clare Brittain, Michelle Cole, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014Susanne Jacobsson, Daniel Golparian, Michelle Cole, et al.
The Lancet Regional Health. Europe|December 19, 2023
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohortPeter D Kirwan, Victoria J Hall, Sarah Foulkes, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2024
Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysisHelen Fifer, Michel Doumith, Luciana Rubinstein, et al.
The New England Journal of Medicine|February 16, 2022
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous InfectionVictoria Hall, Sarah Foulkes, Ferdinando Insalata, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Infection|November 5, 2023
Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022Victoria J Hall, Ferdinando Insalata, Sarah Foulkes, et al.
Infection and Immunity|March 28, 2018
Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial InfectionDouglas J Fraser-Pitt, Derry K Mercer, Daniel Smith, et al.
Health Technology Assessment (Winchester, England)|May 18, 2019
Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCTJonathan Dc Ross, Jan Harding, Lelia Duley, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2016
Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapyMarcus J Pond, Catherine L Hall, Victoria F Miari, et al.
Lancet (London, England)|May 7, 2019
Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trialJonathan D C Ross, Clare Brittain, Michelle Cole, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014Susanne Jacobsson, Daniel Golparian, Michelle Cole, et al.
The Lancet Regional Health. Europe|December 19, 2023
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohortPeter D Kirwan, Victoria J Hall, Sarah Foulkes, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2024
Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysisHelen Fifer, Michel Doumith, Luciana Rubinstein, et al.
The New England Journal of Medicine|February 16, 2022
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous InfectionVictoria Hall, Sarah Foulkes, Ferdinando Insalata, et al.
Pageof 4